Stroke

Stroke is a peer-reviewed medical journal published monthly by Lippincott Williams & Wilkins on behalf of the American Heart Association. It covers research on cerebral circulation and related diseases, including clinical research on assessment of risk for stroke, diagnosis, prevention, and treatment, as well as rehabilitation."Dr. Marc Fisher becomes editor-in-chief of Stroke". News Releases. American Heart Association. http://www.newsroom.heart.org/index.php?s=43=1069. Retrieved 2011-05-06.  According to the Journal Citation Reports, the journal has a 2010 impact factor of 5.756, ranking it 13th out of 185 journals in the category "Clinical Neurology" and 7th out of 66 journals in the category "Peripheral Vascular Disease". The current editor-in-chief is Marc Fisher (University of Massachusetts Medical School).

Publisher
Lippincott Williams & Wilkins on behalf of the American Heart Association
Country
United States
History
1970–present
Website
http://stroke.ahajournals.org
Impact factor
5.756 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Medications

Beta blockers can repair malformed blood vessels in the brain

Propranolol, a drug that is efficacious against infantile haemangiomas ("strawberry naevi," resembling birthmarks), can also be used to treat cerebral cavernous malformations, a condition characterized by misshapen blood ...

Health

Is soda bad for your brain? (and is diet soda worse?)

Americans love sugar. Together we consumed nearly 11 million metric tons of it in 2016, according to the US Department of Agriculture, much of it in the form of sugar-sweetened beverages like sports drinks and soda.

Neuroscience

Having a purpose in life may improve health of aging brain

Having a strong sense that your life has meaning and direction may make you less likely to develop areas of brain damage caused by blockages in blood flow as you age. This research is reported in the American Heart Association's ...

Medical research

Robot may accelerate trials for stroke medications

The development of drugs to treat acute stroke or aid in stroke recovery is a multibillion-dollar endeavor that only rarely pays off in the form of government-approved pharmaceuticals. Drug companies spend years testing safety ...

page 1 from 33